This hypothesis is further supported by earlier reports on adult patients with CML showing that pathogenic variants in ASXL1 are mostly already present in CP, but pathogenic variants in RUNX1 and ABL1 emerge during progression to BP.39, 45, 46. Here, RUNX1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.